Endothelial Thioredoxin-Interacting Protein Depletion Reduces Hemorrhagic Transformation in Hyperglycemic Mice after Embolic Stroke and Thrombolytic Therapy

Endothelial Thioredoxin-Interacting Protein Depletion Reduces Hemorrhagic Transformation in Hyperglycemic Mice after Embolic Stroke and Thrombolytic Therapy

We hypothesize that endothelial-specific thioredoxin-interacting protein knock-out (EC-TXNIP KO) mice will be more resistant to the neurovascular damage (hemorrhagic-transformation-HT) associated with hyperglycemia (HG) in embolic stroke. Adult-male EC-TXNIP KO and wild-type (WT) littermate mice wer...

Full description

Bibliographic Details
Main Authors:	Mohd. Salman, Saifudeen Ismael, Lexiao Li, Heba A. Ahmed, Michelle A. Puchowicz, Tauheed Ishrat
Format:	Article
Language:	English
Published:	MDPI AG 2021-09-01
Series:	Pharmaceuticals
Subjects:	hyperglycemia endothelial-specific TXNIP deletion tissue plasminogen activator hemorrhagic transformation embolic stroke
Online Access:	https://www.mdpi.com/1424-8247/14/10/983

Similar Items

Thioredoxin interacting protein regulates age-associated neuroinflammation
by: Saifudeen Ismael, et al.
Published: (2021-08-01)

Successful thrombolytic therapy with recombinant tissue-type plasminogen activator for massive pulmonary embolism -A case report-
by: Min Soo Kim, et al.
Published: (2010-07-01)

Intra-arterial verapamil improves functional outcomes of thrombectomy in a preclinical model of extended hyperglycemic stroke
by: Sanaz Nasoohi, et al.
Published: (2023-04-01)

Thioredoxin-Interacting Protein as a Novel Potential Therapeutic Target in Diabetes Mellitus and Its Underlying Complications
by: Wondafrash DZ, et al.
Published: (2020-01-01)

Clinical Significance of Stress Hyperglycemic Ratio and Glycemic Gap in Ischemic Stroke Patients Treated with Intravenous Thrombolysis
by: Li G, et al.
Published: (2022-12-01)

Cerebral Embolism Associated with Left Atrial Myxoma That Was Treated with Thrombolytic Therapy
by: Naoto Kohno, et al.
Published: (2012-01-01)

Large saddle pulmonary embolism safely managed by ultrasonic-supported catheter-directed thrombolytic therapy
by: Rajeev Lochan, et al.
Published: (2024-01-01)

Diabetes mellitus: A common comorbidity increasing hemorrhagic transformation after tPA thrombolytic therapy for ischemic stroke
by: Yinghua Jiang, et al.
Published: (2021-09-01)

Thioredoxin-interacting protein in diabetic retinal neurodegeneration: A novel potential therapeutic target for diabetic retinopathy
by: Chengzhi Liu, et al.
Published: (2022-08-01)

TXNIP mediates high glucose-induced mitophagic flux and lysosome enlargement in human retinal pigment epithelial cells
by: Takhellambam S. Devi, et al.
Published: (2019-04-01)

Thioredoxin-Interacting Protein’s Role in NLRP3 Activation and Osteoarthritis Pathogenesis by Pyroptosis Pathway: In Vivo Study
by: Ruba Altahla, et al.
Published: (2024-09-01)

Diabetes regulates fructose absorption through thioredoxin-interacting protein
by: James R Dotimas, et al.
Published: (2016-10-01)

Thioredoxin/Txnip: Redoxisome, As a Redox Switch for the Pathogenesis of Diseases
by: Eiji eYoshihara, et al.
Published: (2014-01-01)

Incidence of Hemorrhagic Complications among Patients Treated with Thrombolytic in Erbil City, Iraq
by: Ahmed F. Hammad, et al.
Published: (2020-12-01)

Immunomodulatory Role of Thioredoxin Interacting Protein in Cancer’s Impediments: Current Understanding and Therapeutic Implications
by: Ramkumar Katturajan, et al.
Published: (2022-11-01)

Use of Ultrasound-Assisted, Catheter-Directed Thrombolysis in a Patient With High-Risk Pulmonary Embolism
by: Karam P. S. Gill, MD, et al.
Published: (2024-02-01)

Hemorrhagic complications of thrombolytic therapy eight years of experience from Banjaluka’s University hospital: Stroke unit
by: Vujković Zoran, et al.
Published: (2016-01-01)

A pan-cancer analysis of thioredoxin-interacting protein as an immunological and prognostic biomarker
by: Xuxue Guo, et al.
Published: (2022-07-01)

Melatonin Alleviates Neuronal Damage After Intracerebral Hemorrhage in Hyperglycemic Rats
by: Liang F, et al.
Published: (2020-07-01)

Discovering the anti-diabetic potential of pomegranate peel metabolites by examining molecular interplay with the thioredoxin-interacting protein
by: Tahira Aslam, et al.
Published: (2024-09-01)

Value of thrombolytic therapy for submassive pulmonary embolism patients
by: Magda A Ahmed, et al.
Published: (2018-01-01)

Deciding on thrombolytic therapy in pulmonary embolism - is there room for lactate?
by: Obradović Dušanka, et al.
Published: (2018-01-01)

Molecular Link between Glo-1 Expression and Markers of Hyperglycemia and Oxidative Stress in Vascular Complications of Type 2 Diabetes Mellitus
by: Nida Ali Syed, et al.
Published: (2023-08-01)

PKC Delta Activation Promotes Endoplasmic Reticulum Stress (ERS) and NLR Family Pyrin Domain-Containing 3 (NLRP3) Inflammasome Activation Subsequent to Asynuclein-Induced Microglial Activation: Involvement of Thioredoxin-Interacting Protein (TXNIP)/Thioredoxin (Trx) Redoxisome Pathway
by: Manikandan Samidurai, et al.
Published: (2021-07-01)

Thioredoxin-interacting protein-activated intracellular potassium deprivation mediates the anti-tumour effect of a novel histone acetylation inhibitor HL23, a fangchinoline derivative, in human hepatocellular carcinoma
by: Yuanjun Lu, et al.
Published: (2023-09-01)

Thrombolytic therapy in bilateral embolism of renal arteries branches
by: Marcelo F. Cassini, et al.
Published: (2003-04-01)

Enhanced Cerebroprotection of Xenon-Loaded Liposomes in Combination with rtPA Thrombolysis for Embolic Ischemic Stroke
by: Tao Peng, et al.
Published: (2023-08-01)

Intravenous Thrombolytic Therapy in Acute Ischemic Stroke
by: Semai Bek, et al.
Published: (2009-12-01)

Unexpected bleeding site post thrombolytic therapy for massive pulmonary embolism
by: Ibraheem AlZaabi, et al.

The Emerging Role of Metabolism in Brain-Heart Axis: New Challenge for the Therapy and Prevention of Alzheimer Disease. May Thioredoxin Interacting Protein (TXNIP) Play a Role?
by: Lorena Perrone, et al.
Published: (2021-11-01)

Transcriptomic Analysis of the Effect of Metformin against Cisplatin-Induced Ototoxicity: A Potential Mechanism of Metformin-Mediated Inhibition of Thioredoxin-Interacting Protein (Txnip) Gene Expression
by: Sehee Lee, et al.
Published: (2022-12-01)

Icariin Ameliorates Palmitate-Induced Insulin Resistance Through Reducing Thioredoxin-Interacting Protein (TXNIP) and Suppressing ER Stress in C2C12 Myotubes
by: Mingxin Li, et al.
Published: (2018-10-01)

Mitochondrial dysfunction mediated by thioredoxin-interacting protein: A crucial determinant in di(2-ethylhexyl) phthalate-induced liver failure
by: Peng Xu, et al.
Published: (2024-03-01)

Reduced-Dose Systemic Fibrinolysis in Massive Pulmonary Embolism: A Pilot Study
by: Ahmet Çağrı Aykan, et al.
Published: (2023-09-01)

Clerodane Diterpenoids with Anti-hyperglycemic Activity from Tinospora crispa
by: Yuan Gao, et al.
Published: (2016-10-01)

O-GlcNacylation Links TxNIP to Inflammasome Activation in Pancreatic β Cells
by: Gaelle Filhoulaud, et al.
Published: (2019-05-01)

Thrombolytic Therapy in Normotensive Patients with Pulmonary Embolism (Data from the Retrospective Study)
by: N. A. Сherepanova, et al.
Published: (2020-11-01)

Exosome-Coated tPA/Catalase Nanoformulation for Thrombolytic Therapy
by: Sara Khalil, et al.
Published: (2023-01-01)

Targeted Delivery of Plasminogen Activators for Thrombolytic Therapy: An Integrative Evaluation
by: Yunn-Hwa Ma, et al.
Published: (2019-09-01)

A Fluorine-19 Magnetic Resonance Probe, Shiga-Y5, Downregulates Thioredoxin-Interacting Protein Expression in the Brain of a Mouse Model of Alzheimer’s Disease
by: Aslina Pahrudin Arrozi, et al.
Published: (2021-09-01)